SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-18-007773
Filing Date
2018-04-06
Accepted
2018-04-06 16:31:05
Documents
1
Period of Report
2018-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A 6APR2018 evok-8ka_20180329.htm 8-K/A 32591
  Complete submission text file 0001564590-18-007773.txt   33725
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36075 | Film No.: 18743548
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences